Combination therapy with lenvatinib and radiation significantly inhibits thyroid cancer growth by uptake of tyrosine kinase inhibitor.
Exp Cell Res. 2021 Jan 1;398(1):112390. doi: 10.1016/j.yexcr.2020.112390. Epub 2020 Nov 21.
Exp Cell Res. 2021.
PMID: 33227314